Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Total Liabilities

Latest as of March 2026: CN¥721.64 Million CNY ≈ $105.60 Million USD

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A total liabilities. Based on the latest financial reports, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has total liabilities worth CN¥721.64 Million CNY (≈ $105.60 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shaanxi Panlong Pharmaceutical Group Lim liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)

Total liabilities of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's total liabilities have evolved over time, based on quarterly financial data.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Competitors by Total Liabilities

The table below lists competitors of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A ranked by their total liabilities.

Company	Country	Total Liabilities
Haymaker Acquisition Corp. 4 NYSE:HYAC	USA	$176.79 Million
BH Co Ltd KQ:090460	Korea	₩446.59 Billion
Yuen Foong Yu Consumer Prod TW:6790	Taiwan	NT$4.66 Billion
cBrain A/S CO:CBRAIN	Denmark	Dkr120.83 Million
Seanergy Maritime Holdings Corp NASDAQ:SHIP	USA	$330.35 Million
ADF Foods Limited NSE:ADFFOODS	India	Rs1.83 Billion
Picpay Holdings Netherlands N.V. Class A Common Shares NASDAQ:PICS	USA	$45.79 Billion
Fiverr International Ltd NYSE:FVRR	USA	$263.48 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Shaanxi Panlong Pharmaceutical Group Lim.

Liquidity & Leverage Metrics

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Total Liabilities Ratios Explained

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.76	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.42	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)

The table below shows the annual total liabilities of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥633.75 Million ≈ $92.74 Million	-1.41%
2024-12-31	CN¥642.84 Million ≈ $94.07 Million	+12.04%
2023-12-31	CN¥573.76 Million ≈ $83.96 Million	-41.64%
2022-12-31	CN¥983.18 Million ≈ $143.87 Million	+88.00%
2021-12-31	CN¥522.97 Million ≈ $76.53 Million	+22.51%
2020-12-31	CN¥426.89 Million ≈ $62.47 Million	+67.95%
2019-12-31	CN¥254.17 Million ≈ $37.19 Million	+23.24%
2018-12-31	CN¥206.24 Million ≈ $30.18 Million	+4.51%
2017-12-31	CN¥197.34 Million ≈ $28.88 Million	+11.70%
2016-12-31	CN¥176.68 Million ≈ $25.85 Million	+22.32%
2015-12-31	CN¥144.44 Million ≈ $21.14 Million	-6.85%
2014-12-31	CN¥155.06 Million ≈ $22.69 Million	+17.88%
2013-12-31	CN¥131.55 Million ≈ $19.25 Million	--

About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

SHE:002864 China Drug Manufacturers - Specialty & Generic

Market Cap

$313.38 Million

CN¥2.14 Billion CNY

Market Cap Rank

#14349 Global

#4241 in China

Share Price

CN¥20.15

Change (1 day)

+0.55%

52-Week Range

CN¥19.41 - CN¥39.20

All Time High

CN¥74.44